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Abstract
We present an extension of the two-class multifactor dimensionality reduction (MDR) algorithm that enables detection and
characterization of epistatic SNP-SNP interactions in the context of a quantitative trait. The proposed Quantitative MDR
(QMDR) method handles continuous data by modifying MDR’s constructive induction algorithm to use a T-test. QMDR
replaces the balanced accuracy metric with a T-test statistic as the score to determine the best interaction model. We used a
simulation to identify the empirical distribution of QMDR’s testing score. We then applied QMDR to genetic data from the
ongoing prospective Prevention of Renal and Vascular End-Stage Disease (PREVEND) study.
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Introduction
The view that the genetic basis of common human diseases can
be explained by sequence variation in a few genetic loci has been
recently replaced by a new appreciation for the complexity of
biological networks and the interplay between proteins that jointly
influence phenotypes [1]. The recent advances in high-throughput
genotyping techniques have made large quantities of genotype
data commonplace in genetic epidemiology studies and therefore
have enabled researchers to interrogate the entire genome.
Researchers have extensively analyzed single SNP effects for a
wide variety of diseases/phenotpyes with variable results, but in
most cases with a large proportion of the genetic component
(heritability) left unexplained. It has been proposed that these
limitations are due to the analytical strategy that limits analyses to
only single SNPs [2], and it is therefore becoming more
commonplace to assess the challenge of identifying SNP-SNP
interactions.
The problem of identifying interactive SNP effects in a case-
control study, which can be formulated as predicting binary
outcomes, has been studied extensively and has demonstrated
great promise in recent years [3–5]. Multifactor Dimensionality
Reduction MDR was developed as a nonparametric and model-
free data mining method for detecting, characterizing, and
interpreting epistasis in the absence of significant main effects in
genetic and epidemiologic studies of complex traits such as disease
susceptibility [3]. The goal of MDR is to change the representa-
tion of the data using a constructive induction algorithm to make
non-additive interactions easier to detect using a classification
method such as naı¨ve Bayes or logistic regression. Comparative
studies [6,7] that use extensive simulations show that MDR has the
best performance when the true multi-SNP effects are non-
additive [2,3,7–12].
Despite the fact that MDR has been extended to various settings
[13–17], there have been few attempts to develop methods that
systematically identify SNP-SNP interactions in relation to
quantitative outcomes such as body mass index, tumor size and
survival time. Because in many cases, analyzing phenotypes as
continuous rather than binary outcomes can be more powerful
due to large variability in the outcome distribution it is important
to develop methods that permit the analyses of continuous traits.
Many methods including Combinatorial Partitioning Method
(CPM) [18], Repeated Partitioning Method (RPM) [19] and U-
statistics [20] were developed to identify interactions for quanti-
tative traits. CPM and RPM are both computationally intensive
and the U-statistics approach is limited to detecting interaction
models with main effects. In 2006, Generalized MDR (G-MDR)
[17] was proposed to extend the MDR algorithm to be applicable
to continuous phenotypes and allow covariate adjustment. In
2011, Model based MDR (MB-MDR) [21] was developed to
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improve MDR using parametric regression; this method can also
be applied to continuous outcomes. However, neither G-MDR
nor MB-MDR provides a computationally efficient algorithm that
is easy to implement. MB-MDR is implemented in R (http://
www.r-project.org/) but it can only search over all one-way and
two-way interaction models. G-MDR still requires a dichotomous
outcome in the data file. Furthermore, the success rate of each
algorithm on continuous outcomes was not evaluated using
simulations.
In the current paper, we present an extension of the multifactor
dimensionality reduction (MDR) algorithm to detect and charac-
terize epistatic interactions in the context of a quantitative
outcome (QMDR). We first present the type-I error and success
rate of the proposed method using simulated datasets under
different epitasis models. We then present the results of QMDR
applied to genetic data from the ongoing prospective Prevention of
Renal and Vascular End-Stage Disease (PREVEND) study.
Materials and Methods
In this section, we introduce T statistics and describe how they
can be used in the MDR framework in the context of quantitative
outcomes.
MDR Algorithm
Traditional MDR is a data reduction approach that identifies
multi-locus combinations of genotypes that are associated with
either high or low risk of disease and uses them to define a new
single high/low risk attribute. The general process of defining a
new attribute as a function of two or more other attributes is
referred to as constructive induction or attribute construction [22].
Constructive induction using MDR for binary outcomes (e.g. case-
control status) is accomplished in the following way:
1. Assume there are m SNPs in the dataset; in order to examine a
K-order interaction, select K SNPs from the m SNPs.
Figure 1. Empirical distribution of the 10-fold cross-validated testing score. The three curves on each figure represent the testing score
from 2-way, 3-way and 4-way models.
doi:10.1371/journal.pone.0066545.g001
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2. Construct a contingency table using these K SNPs and
calculate case-control ratios for each multi-locus genotype.
3. Let R be the ratio of cases to controls in the whole dataset. For
each multi-locus genotype, if the ratio of cases to controls
exceeds T, it is considered high-risk. Otherwise, it is considered
low-risk. Once all genotypes are labeled ‘high-risk’ and ‘low-
risk’, a new binary attribute is created constructed by pooling
the ‘‘high risk’’ genotype combinations into one group and the
‘‘low risk’’ into another group.
MDR uses a simple probabilistic classifier that is similar to a
naı¨ve Bayes classifier [8] to model the relationship between
variables constructed using MDR and case-control status. Naı¨ve
Bayes classifiers were assessed using balanced accuracy [23].
Balanced accuracy is defined as the arithmetic mean of sensitivity
and specificity:
1=2 TP= TPzFNð ÞzTN= TNzFPð Þð Þ
~ sensitivityzspecificityð Þ=2
ð1Þ
where TP are true positives, TN are true negatives, FP are false
positives, and FN are false negatives. For each dataset, MDR
evaluates all possible K-way interactions and identifies the best
model using balanced accuracy. To determine the K loci that give
the best model overall, MDR uses ten-fold cross-validation:
1. Divide the dataset into 10 partitions. Using 9/10 of the data as
a training set and the rest as a testing set.
2. Compute the training balanced accuracy for each K-way
interaction in the training set.
3. Using the K-way model that has the best training balanced
accuracy, predict the case-control status in the testing set.
4. Repeat steps two-three 10 times so that each partition is
included in the testing set once.
5. Compute a testing balanced accuracy by using the case-control
predictions and actual case-control status for all 10 testing sets.
For the K-way models that are chosen from the training sets,
record how many times each is identified as the best model
(cross-validation consistency).
The best MDR model is selected as that with the maximum
testing balanced accuracy and highest cross-validation consistency.
The latter is used as a tie-break. If both statistics are tied, then the
more parsimonious model is chosen as the overall best model.
Quantitative MDR Algorithm
Quantitative MDR (QMDR) extends the MDR algorithm
described above to work with quantitative or continuous
phenotypes. Instead of comparing the case-control ratio of each
multi-locus genotype to a fixed threshold R, we propose to
compare the mean value of each multi-locus genotype to the
overall mean. Constructive induction by QMDR is done as
follows:
1. Assume there are m SNPs in the dataset; in order to examine a
K-order interaction, select K SNPs from the m SNPs.
2. For each multi-locus genotype combination defined by the K
SNPs, calculate the mean value and compare it with the overall
mean.
3. If the mean value from the genotype combination is larger than
the overall mean, the corresponding genotype is considered
high-level. Otherwise, it is considered low-level. Once all of the
genotypes are labeled ‘high-level’ and ‘low-level’, a new binary
attribute is created by pooling the ‘‘high-level’’ genotype
combinations into one group and the ‘‘low-level’’ into another
group.
With quantitative outcomes, we cannot use balanced accuracy
to characterize the relationship between the QMDR attribute and
phenotype. Instead, we compare the outcome between high and
low level groups defined by the QMDR attribute using a T-test
and then use the T-statistic as a training score to choose the best
model. The cross-validation procedure for QMDR is the same as
that used in traditional MDR. The difference is that we define the
training score and testing score from the T-test (replacing the
training and testing balanced accuracy). We use the training score
to determine the best K-order interaction model and use the
maximum testing score to identify the best overall model. When
there is no SNP effect, QMDR attributes from the testing set are
equivalent to ones randomly assigned to the high or low level
group. Therefore we expect that the null distribution of the testing
score follows a normal distribution with mean 0. We can then use
an empirical null distribution to estimate the p-value of the chosen
model. In the next section, we will use simulated data to compare
empirical p-value and the permutated p-value to verify the above
hypothesis.
Simulations
To demonstrate the strength of the proposed method, we
designed two simulations: Simulation I focused on estimating the
threshold for 5% type I error using a quantitative outcome and
SNPs that are independent of each other. Simulation II aimed at
estimating the success rate of our proposed QMDR with a
quantitative outcome and two functional interacting SNPs
embedded within a set of 18 independent SNPs.
Simulation I. The goal of simulation I was to study the
testing score’s null distribution. To this end, we let the SNP
number m = {10, 20, 50} and the sample size n = {200, 400, 800,
1600}. For each combination of m and n, we simulated m SNPs
with a minor allele frequency drawn from a uniform distribution
over the interval (0.1, 0.5) using Bernoulli distribution. We then
simulated n continuous outcomes from a standard normal
distribution. We simulated the SNP data and outcomes indepen-
dently of each other so that there is no association between SNPs
and outcome. We repeated this to create 2000 null datasets for
each m by n combition. Thus, we created 24,000 total datasets. All
simulations were carried out in R (http://cran.r-project.org/). We
ran QMDR for each dataset and searched over all 1–4 way
interactions. The testing score was obtained using a 10-fold cross-
validation.
Simulation II. The goal of simulation II was to study the
success rate of the proposed method. We also compared QMDR
with the original MDR algorithm and GMDR to demonstrate the
success rate gained by using the continuous outcome.
We first generated datasets based on different penetrance
functions. We previously developed a total of 70 different
penetrance functions that define a probabilistic relationship
between the outcome and SNPs where the outcome is dependent
on genotypes from two loci in the absence of any marginal effects
[23]. These purely epistatic models were distributed evenly across
seven broad-sense heritabilities (0.01, 0.02, 0.05, 0.1, 0.2, 0.3, and
0.4) and two different minor allele frequencies (0.2 and 0.4) using
Bernoulli distribution, where all functional SNPs in the data set
had either one or the other minor allele frequencies. A total of five
models for each of the 14 heritability-allele frequency combina-
tions were generated for a total of 70 models. We also vary the
sample size to include sample size n = {400, 800, 1600}. Since the
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original outcome is case-control status and the penetrance function
denotes the probability of being a case for each genotype
combination, we make the following change to simulate contin-
uous outcome using the same penetrance functions:
Let fij be the element from the ith row and jth column of a
penetrance function. and are the two functional interacting SNPs.
The Quantitative outcome was simulated from a normal
distribution
yD SNP1~i, SNP2~jð Þ*N(fij ,1) ð2Þ
We repeated 100 times to get 100 datasets for each model.
Real Data Analysis
The sample analyzed in this study was obtained from the
ongoing prospective Prevention of Renal and Vascular End-Stage
Disease (PREVEND) study [24]. The PREVEND study was
designed to prospectively investigate the natural course of
albuminuria and its relation to renal and cardiovascular disease
in a large cohort drawn from the general population. Details of the
study protocol have been described previously [25,26]. In
summary, during 1997–1998, all 85,421 inhabitants of the city
of Groningen, the Netherlands, from the ages of 28 to 75 years old,
were sent a one-page postal questionnaire. After exclusion of
subjects with type 1 diabetes mellitus, females who were possibly
pregnant, and males and females not able or willing to participate,
a total of 6,000 subjects with a urinary albumin concentra-
tion$10 mg l21 and a random control sample of subjects with a
urinary albumin concentration,10 mg l21 (n = 2592) completed
the screening protocol and formed the baseline PREVEND cohort
(n = 8592). From this cohort, we selected a random sample of 2527
subjects (1338 females and 1189 males) as being representative of
the entire population from which the PREVEND cohort was
selected. These individuals were used in the present study to
explore genetic predictors of tissue plasminogen activator (t-PA)
Figure 2. Empirical distribution of the 10-fold cross-validated testing score. The three curves on each figure represent testing scores from
datasets with 10, 20, and 50 SNPs.
doi:10.1371/journal.pone.0066545.g002
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and plasminogen activator inhibitor-1 (PAI-1) levels in the general
population. We examined 7 polymorphisms from the renin-
angiotensin, bradykinin and fribrinolytic systems that have been
previously reported [24].
We carried out analysis in females and males separately since
the distributions of t-PA and PAI-1 are gender specific. For each
gender and expression combination, we first used an ANOVA and
F-test to identify the main effect of each polymorphism. We
filtered out the significant main effects via a two-step procedure:
First, we fit a linear regression with PAI-1 or tPA plasma
concentrations and all of the SNPs with a significant main effect
(p,0.05). Secondly, we applied QMDR using the residual as the
new quantitative trait to search over all possible two-way, three-
way and four-way interactions. We used 10-fold cross-validation to
determine the best overall model. We then ran a 10,000-fold
permutation testing to estimate the p-value of the chosen model.
Finally we compared the p-value obtained through permutation
testing with that estimated using the empirical scores from
simulation I.
Results
Simulation I Results
The testing scores were expected to follow a standard normal
distribution, since when the sample size is large (n .50), the T-
statistics are asymptotically standard normal. However, from
figure 1, the empirical distributions were not exactly standard
normal. The estimated standard deviation was 1.6 with a slight
right skew. We believe that this deviation was due to extra
variation in the cross-validation procedure that resulted from the
overlap among the training sets.
On the other hand, as seen in figure 1 and 2, we can tell that the
null distributions are similar across different sample sizes, number
of SNPs and interaction orders. The right tail regions, in
particular, show almost perfect overlap. This indicates that we
can use the 95th quantile of the empirical distribution as a
threshold to eliminate weak QMDR models, which is exactly what
permutation testing can offer. Since the null distributions are
‘‘invariant’’, we can potentially save a lot of computing time by
comparing the testing score with a pre-calculated empirical
distribution. In table 1, we used the 95th quantile of datasets with
400 samples to estimate the type I error. The estimated type I
error was tightly distributed around 5% with a range from 4.1% to
6.2%.
Simulation II Results
For each dataset, we used a median cut off to change the
continuous outcome to a dichotomous outcome for analysis with
the original MDR.
We applied MDR, GMDR and QMDR to search for the best
one-way, two-way and three-way interaction model. The overall
best model is determined by testing score and CV consistency. We
counted the number of times that a SNP pair was correctly
identified and divided that number by the total number of datasets
(1000 for this simulation) to get the estimated success rate, as
shown in table 2. QMDR and GMDR is generally more powerful
than MDR. QMDR performs better than GMDR when the
sample size is high or the heritability is above 0.1. However,
GMDR performs better in low sample size and low heritability
settings. One interesting thing to note is that GMDR’s success rate
increase very slowly (ranging from 82% to 83%) at heritability 0.4
as sample size increases. The reason is that GMDR use balanced
accuracy to rank interaction models. The variance of the
quantitative outcome is ignored at this stage. The computing time
for 100 datasets for GMDR is 7.9 min vs 4.4 min for QMDR.
This indicates that QMDR is more efficient than GMDR.
Real Data Results
The ANOVA for PAI-1 revealed a significant main effect from
PAI 4G/5G with F-test p-value of 0.0006 for female and 0.002 for
male. This verified previous findings [24,27]. For tPA, we found a
significant main effect of ATR1AC in females only (p = 0.04) and
none in males.
After adjusting out the main effect of PAI 4G/5G and
ATR1AC using residuals, we ran QMDR to identify interaction
models. In table 3, we list the best interaction models identified
from 10-fold cross-validation for PAI-1 and tPA expression in
males and females. The best model for PAI-1 in females is a four-
way interaction of BR2_58CT, ATR1AC, ACEID and
BRB2EX1. The 10,000 permutation testing revealed a significant
p-value of 0.014. Since we also found a significant main effect of
PAI 4G/5G, we ran a linear regression model with PAI 4G/5G
and an interaction between BR2_58CT, ATR1AC, ACEID and
Table 1. Estimated type I error using the 95th quantile of the
testing scores from datasets with 400 samples.
Type I error rate n = 200 n= 400 n= 800 n= 1600
2-way
m= 10 4.8% 5.4% 5.8% 5.9%
m=20 5.2% 5.1% 6.1% 5.5%
m=50 5.5% 5.3% 5.8% 6.2%
3-way
m= 10 4.8% 4.1% 5.6% 6.2%
m=20 5.3% 5.8% 5.9% 5.3%
m=50 4.2% 4.4% 6.1% 5.4%
4-way
m= 10 4.1% 4.0% 4.9% 6.3%
m=20 4.5% 4.8% 4.9% 4.5%
m=50 4.1% 4.3% 4.6% 4.7%
doi:10.1371/journal.pone.0066545.t001
Table 2. Success rate table for MDR, GMDR and QMDR.
Success rate h = 0.4 h = 0.3 h = 0.2
Heritability
h = 0.1 h = 0.05 h= 0.02 h= 0.01
n=400
QMDR 80.7% 69.3% 42.0% 12.7% 2.2% 0.6% 0.2%
GMDR 81.9% 73.2% 46.1% 15.2% 3.8% 0.8% 0.6%
MDR 66.4% 50.4% 26.7% 7.6% 1.8% 0.7% 0.6%
n=800
QMDR 85.4% 83.7% 74.6% 41.1% 8.6% 1.7% 0.7%
GMDR 83.1% 83.0% 76.0% 43.9% 10.0% 1.5% 0.8%
MDR 85.0% 79.8% 60.6% 26.1% 4.7% 1.1% 0.4%
n=1600
QMDR 83.4% 80.1% 78.0% 75.0% 25.6% 5.3% 1.3%
GMDR 82.2% 77.6% 75.7% 76.5% 30.5% 6.5% 1.8%
MDR 81.9% 80.1% 78.6% 58.1% 15.8% 3.7% 1.2%
doi:10.1371/journal.pone.0066545.t002
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BRB2EX1 as the predictors and found that those 5 SNPs could
explain 9.5% of the total variance of PAI-1 in females.
Considering the sample size (.1000) and the continuous outcome,
this indicated a strong association between PAI-1 and the 5 SNPs
in females. The best interaction models from the other 3 datasets
were not significant as determined by the permutation testing.
One interesting thing to note was that removing the main effect
did not exclude it from being chosen in the best interaction model.
For example, PAI 4G/5G’s main effect was removed from PAI-1
in males and the best interaction model is four-way interactions of
PAI 4G/5G, BR2_58CT, ACEID and BRB2EX1. We note that
the amount of variance explained by the significant model was
much better than previously reported using other analytical
methods.
The empirical p-values were very close (difference less than 2%)
to those obtained from permutation tests. For p-values that are
within the critical region, the empirical p-values are more accurate
(1.4% vs 1.8%). This suggests that we can rely on the empirical
distribution from simulations to estimate the significance of
QMDR models, potentially saving months of computation time
in genome-wide association studies.
Discussion
In this paper, we presented a novel algorithm to identify SNP
interactions associated with a quantitative outcome. There are two
unique contributions from this paper: first of all, we offer a
computationally efficient algorithm, QMDR, to identify epistatic
models that are associated with a quantitative outcome. We have
distributed free Java-based software for this QMDR on source-
forge.net. Secondly, we present a testing score that is ‘‘invariant’’
for all sample sizes, number of SNPs and interaction orders.
Simulations and real data analyses both showed that the empirical
p-value is very close to permutated p-value thereby permitting a
significant reduction in computing time.
QMDR changes the representation of the data by pooling
different genotype combinations into a two-level single attribute.
This challenges the traditional analysis method of using many
dummy variables to represent every genotype combination. Due to
limitations in sample size, some of the dummy variables used in
traditional models can be represented by very sparse or no data.
This makes the modelling of high-order combinations very
difficult. QMDR solves this dilemma elegantly by collapsing all
high-level genotypes and all low-level genotypes into a two level
attribute. This not only makes it easier to detect higher order
interaction terms, but also makes it possible to incorporate the
QMDR attribute into other statistical and machine learning
algorithms, such as Boosting [28] and neural networks. This will
allow researchers to build more accurate models that involve
multiple genotype combinations. As we can see from real data
results, QMDR successfully identifies a four-way interaction model
that is strongly associated with female PAI-1 levels. This is good
example of how QMDR can gain biological information above
that previously obtained using a more traditional ANOVA
approach [24].
QMDR also offers a cross-validation procedure to pick the best
model based on the testing score. Since high-order interactions
tend to have better training scores than low-order interactions,
these cross-validation procedures are necessary to limit model
over-fitting. The QMDR algorithm also explores the empirical
distribution of the testing score from the null models and applies it
to estimate the significance of the selected model. From the
simulation, we demonstrated that QMDR can detect the presence
of multiplicative interaction models, even when main effects are
not statistically significant. These epistatic combinations tend to be
missed or dropped when using traditional linear regression
approaches. Last but not least, QMDR is computationally
efficient. One of the first algorithms developed to explore gene-
gene interactions was the Combinatorial Partitioning Method
(CPM) [18]. While elegant, CPM’s functionality is limited by its
inefficiency; its computing time increase exponentially with the
number of genes examined (0(2
r
)). In contrast, QMDR’s
computing time is 0(r2) for two-way interactions. QMDR is has
a nearly two-fold computational speed advantage over GMDR, as
demonstrated through simulations. This increase in speed is vitally
important and makes QMDR a feasible method to use when
exploring large datasets such as genome-wide association studies.
Despite the advantages stated above, one limitation to the
approach is that the QMDR method does not have a way to adjust
for covariate effects such as age, gender and smoking status, an
often necessary step to obtain an unconfounded SNP interactions-
outcome association. Investigators can, however, first fit a model
with potential confounders and the outcome of interest and then
use the residuals in QMDR, as we did to adjust for SNP main
effects in this paper. However, if there are too many covariates,
this approach may overfit the data and sometimes fail due to
limited sample size. One strength of QMDR is that it can be
extended to the analysis of interactions among non-genetic
variables as well as gene-environment interactions. For example,
QMDR will facilitate pharmacogenomic analyses by identifying
combinations of drug treatments and genotypes that affect time to
progression.
In summary, we demonstrate that QMDR is a promising
dimension reduction method for the efficient identification of SNP
interactions. We believe that it will play an important role as part
of a research strategy to understand genetic influences on disease
outcomes that embraces the complexity of the genotype-pheno-
type mapping relationship.
We have uploaded Java-based QMDR software as part of
MDR 3.0 to: http://sourceforge.net/projects/mdr/.
Table 3. Best overall model identified by QMDR.
File Best model CV testing score Empirical P-value Permutated P-value
PAI (Female) BR2_58CT & ATR1AC & ACEID & BRB2EX1 3.46 0.018 0.014
PAI (Male) PAI4G5G & BR2_58CT & ACEID & BRB2EX1 0.98 0.244 0.259
tPA (Female) BR2_58CT & ACEID 1.60 0.152 0.167
tPA (Male) PAI4G5G & BR2_58CT & BRB2EX1 1.11 0.222 0.241
doi:10.1371/journal.pone.0066545.t003
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